previous compound ID: 2401 next compound
InChIKey: VWPOSFSPZNDTMJ-UCWKZMIHSA-N
SMILES: CC(C)(C)NCC(COC1=CC=CC2=C1C[C@@H]([C@@H](C2)O)O)O

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"J Goepp" "D Rotin" "E Matthes" "DY Thomas" "SD Macknight" "B Kus" "R Robert" "JW Hanrahan" "GW Carlile" "J Liao"

chemical graph of compound 2401





CID is 39147
synonyms found at PubChem are:
nadolol, 42200-33-9, Corgard, Solgol, SQ-11725, Anabet, Corgaretic, Nadic, Nadololum [INN-Latin], (2R,3S)-5-(3-(tert-Butylamino)-2-hydroxypropoxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol, (2R,3S)-5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol, Corgard (TN), Nadolol [USAN:BAN:INN:JAN], CHEMBL649, Nadololum, MLS000028580, VWPOSFSPZNDTMJ-UCWKZMIHSA-N, SQ 11725, SMR000058975, DSSTox_CID_3342, EN300-50860, DSSTox_RID_76983, DSSTox_GSID_23342, CCRIS 1048, HSDB 6532, EINECS 255-706-3, (2R,3S)-5-({3-[(1,1-dimethylethyl)amino]-2-hydroxypropyl}oxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol, CPD000058975, 2,3-cis-1,2,3,4-Tetrahydro-5-((2-hydroxy-3-tert-butylamino)propoxy)-2,3-naphthalenediol, 2,3-Naphthalenediol, 5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-1,2,3,4-tetrahydro-, 5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-1,2,3,4-tetrahydro-2,3-naphthalenediol, SR-01000000251, 2,3-Naphthalenediol, 5-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-1,2,3,4-tetrahydro-, NCGC00016851-01, Prestwick_108, Corzide (TN), Anabet (TN), CAS-42200-33-9, Solgol (TN), Apo-Nadol (TN), Alti-Nadolol (TN), Novo-Nadolol (TN), SQ11725, Spectrum_001643, Opera_ID_1099, Prestwick0_000818, Prestwick1_000818, Prestwick2_000818, Spectrum2_001546, Spectrum3_001586, Spectrum4_000193, Spectrum5_001255, D05SHK, AC1Q1MO3, AC1Q77IZ, SCHEMBL4177, Nadolol, analytical standard, BSPBio_003152, GTPL554, KBioGR_000765, KBioSS_002123, cid_39147, MLS001148087, MLS002548875, DivK1c_000427, Nadolol (JP17/USP/INN), SPECTRUM1503260, SPBio_001392, SPBio_002636, INV102, DTXSID3023342, Nadolol 1.0 mg/ml in Methanol, BDBM25766, CTK4I5836, HMS501F09, KBio1_000427, KBio2_002123, KBio2_004691, KBio2_007259, KBio3_002652, INV-102, MolPort-003-666-474, NINDS_000427, HMS1570D17, HMS1922O05, HMS2093A15, HMS2233E12, HMS3259C07, HMS3714D17, Pharmakon1600-01503260, AC1L2151, Tox21_110646, CCG-39324, MFCD00079476, NSC758430, AKOS015895037, Tox21_110646_1, API0003480, DB01203, NC00464, NSC-758430, RTR-032791, VA11340, IDI1_000427, SMP1_000203, NCGC00021623-03, NCGC00021623-05, NCGC00089811-02, LS-94578, SAM002264627, SAM002548970, SC-78480, SBI-0051806.P002, AX8143086, KB-206505, FT-0630624, VU0239635-6, D00432, AB00052338_13, 200N339, SR-01000000251-2, SR-01000000251-3, BRD-A87606379-001-03-4, BRD-A87606379-001-13-3, Nadolol, European Pharmacopoeia (EP) Reference Standard, Nadolol, United States Pharmacopeia (USP) Reference Standard, 1403-22-1